Asian Spectator


The Times

.

Mangroves Documentary Premieres, Exploring How Cities and Wetlands Coexist

SHENZHEN, CHINA – Media OutReach Newswire – 17 November 2026 – Guangdong Radio and Television has unveiled Mangroves, a three-part ecological documentary filmed in 4K ultra-high de...

Alliance Ventures Invests in Transit to Advance Multi-Modal Tr...

PARIS, TOKYO, and YOKOHAMA, Japan, Nov. 6, 2018, /PRNewswire-AsiaNet/-- Transit's mobile app aggregates and maps real-time transportation data, functional in more than 175 metropolitan areas...

SAP Launches SAP Build to Unleash Business Expertise - Partner...

LAS VEGAS, Nov. 16, 2022 /PRNewswire-AsiaNet/ -- SAP SE (NYSE: SAP) ( https://c212.net/c/link/?t=0&l=en&o=3710088-1&h=1533971141&u=http%3A%2F%2Fwww.sap.com%2F&a=SAP+SE )a...

Rokt appoints CFO, Deputy CFO Chief People Officer to prepar...

NEW YORK, July 8, 2020 /PRNewswire-AsiaNet/ -- -- E-commerce tech company continues to invest in strengthening the executive team with appointment of new CFO, Michael Gordon, Deputy CFO, La...

C.P. Intertrade releases high-end Hom Mali Rice brand Hug Phayao

BANGKOK, Nov 26, 2019 - (ACN Newswire) - On November 15, C.P. Intertrade Co., Ltd (brand: Royal Umbrella) held the 3rd World's Hom Mali Rice Harvesting Day in Phayao, one of the major agric...

FishyHub Singapore Blazes the Trail in Aquarium E-Commerce with Newly Launched Social Platform

SINGAPORE - Media OutReach - 7 February 2022 - As the pioneering marketplace for aquarium e-commerce in Southeast Asia, FishyHub takes one step further with its new social commerce...

Hong Kong Sports and Leisure Expo to Return alongside Book Fair

From L: Mr PiG, Game Master, Safe Archery Fun; L T Kwan, Manager, Camera Department of Shriro (HK) Ltd; Annie Chang, Manager, Exhibitions, HKTDC; Daniel Lam, Senior Exhibitions Manager, HKTD...

NineSmart Honored for Outstanding Smart Property Management Platform - PropTech at the 2025 Smart Living Partnership Awards

HONG KONG SAR - Media OutReach Newswire - 10 November 2025 - IoT PropTech solutions provider NineSmart has announced its win at 2025 Smart Living Partnership Awards, organized by etnet and ...

Hoyos Announces $100 Million Global Hacker Crypto Challenge

NEW YORK, July 2, 2018 /PRNewswire-AsiaNet/ -- - New Global Utility Token and Wallet Most Secure In IndustryHoyos Integrity Corporation ("HOYOS") (https://www.hoyosrisen.io/ ), a global Secu...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegaluk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girisStreamEastStreamEastjojobetcialis 20 mg fiyat